Attention Deficit Hyperactivity Disorder
Launched by NANTES UNIVERSITY HOSPITAL · Jan 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at patients who have both Attention Deficit Hyperactivity Disorder (ADHD) and an addiction, such as substance use disorder or behavioral addiction. The goal is to collect important information about these patients over two visits: one when they first join the study and another after 12 months. The information gathered will help understand how these conditions affect each other and how best to treat them.
To be eligible for the trial, participants need to be at least 15 years and 3 months old and must have received a diagnosis of ADHD and an addiction within the last six weeks. They should also be new to treatment with a specific medication called MPH, which is commonly used to help manage ADHD. Participants will need to attend both visits, and they should be comfortable speaking and understanding French, as this is important for data collection. This study is an opportunity to contribute to research that could improve treatment for others facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria :
- • Patients aged over 15 years and 3 months
- • For whom a diagnosis of ADHD has been confirmed less than 6 weeks ago
- • For whom the diagnosis of one or more addictive disorder(s) (substance use disorder or behavioral addiction) has been confirmed
- • Meeting the indication for treatment with MPH according to European recommendations (Kooij et al., 2019)
- • For patients who can actually benefit from MPH: who have not yet started taking MPH
- • Social security affiliates
- Exclusion Criteria :
- • Presenting disorders of higher cognitive functions (at the discretion of the referring clinician or the investigator making the inclusion), making data collection impossible
- • Presenting difficulties in reading or writing the French language making data collection impossible
- • Unable to commit to being available for the 2 visits planned as part of the cohort
- • Under guardianship or legal protection
About Nantes University Hospital
Nantes University Hospital, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific exploration with patient care, fostering collaborations among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Nantes University Hospital aims to contribute to the development of effective therapies and interventions that enhance patient outcomes and overall public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tours, , France
Nantes, Loire Atlantique, France
Brest, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported